Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/23399
Title: Surgical therapy, incidence of recurrence after limbal autograft transplantation and surgical technique without transplantation
Authors: Cheleva Markovska, Vesna 
Antova M.
Djajkovska E.
Issue Date: 2002
Publisher: Ophthalmological Society of Northen Greece
Conference: 35 th Panhellenic Ophthalmological Congress
Abstract: Aim: To evaluate the success rates of surgical techniques for primary pterigium: pterigium excision with limbal autograft transplantation and pterigium excision with complete suture of conjunctiva without transplantation Methods: 75 cases with primary pterigium was prospectively reviewed. Outcome was evaluated in terms of recurrence of pterigia onto the cornea .The patients were divided into two groups.4 0 eyes were operated by limbal autograft transplantation (20 cases by pterigium encroaches the cornea 3mm and 20 cases by pterigium encroaches the cornea 3mm and more ). 35 cases were operated by pterigium excision with complete suture of conjunctiva without transplantation 20 cases by pterigium encroaches the cornea 3mm and 15 cases by pterygium encroaches the cornea 3mm and more). Results: Mean follow up was 12 months (2-24 months). 4 out of 40 recurred (10%) after the limbal autograft transplantation, while 14 of 35 cases recurred (40%) after the pterigium excision with complete suture of conjunctiva without transplantation. One surgeon performed the surgery. Conclusion: Conjunctiva-limbus autografts in pterigia have excellent efficacy against within the first year.
URI: http://hdl.handle.net/20.500.12188/23399
Appears in Collections:Faculty of Medicine: Conference papers

Files in This Item:
File Description SizeFormat 
35th Panhellenic Ophthalmological Congress Vesna Cheleva 2002.pdf6.54 MBAdobe PDFView/Open
Show full item record

Page view(s)

19
checked on May 3, 2024

Download(s)

2
checked on May 3, 2024

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.